|
|
News Breaks | | | | February 5, 2013 | | 07:45 EDT |  | JEC, GSK | Jacobs Engineering renews alliance contract with GSK in Singapore
Jacobs Engineering Group (JEC) has renewed its contract with Glaxo Wellcome Manufacturing Pte Ltd (GSK) as alliance contractor at GSK’s two manufacturing facilities in Singapore. The renewal is a continuation of the initial alliance program with GSK in Singapore. Officials did not disclose the contract value, however noted the contract is for two years, with the option to be renewed for an additional two years. Under the terms of the alliance contract, Jacobs is providing engineering, procurement, project management, construction management and validation services. | |
|
News For JEC;GSK From The Last 14 Days Check below for free stories on JEC;GSK the last two weeks. |
|
|
| May 21, 2013 | | 07:44 EDT |  | GSK | Sachs Associates to host a forum
 Subscribe for More Information | | | 07:07 EDT |  | GSK | Theravance pullback on Elan bid a buying opportunity, says Piper Jaffray
Subscribe for More Information | | | May 14, 2013 | | 07:50 EDT | | JEC | Jacobs Engineering awarded contract by Central Texas Regional Mobility Authority
Subscribe for More Information | | | 07:48 EDT | | JEC | Jacobs Engineering renews frame agreement with Borealis
Subscribe for More Information | | | 07:24 EDT | | GSK | EBD Group to host a conference
BioTrinity 2013 is being held in Newbury, England on May 14-16. | | | May 13, 2013 | | 16:25 EDT |  | GSK | On The Fly: Closing Wrap
Stocks on Wall Street were little changed from their opening levels as investors weighed the potential end of the Fed's quantitative easing program against a better than expected report on retail sales. The Wall Street Journal's Jon Hilsenrath suggested in a report over the weekend that the Federal Reserve has mapped a QE exit strategy. The report paired with the retail sales data left the market lacking conviction in either direction today, as the averages spent the majority of the session range-bound near the flatline. ECONOMIC EVENTS: In the U.S., retail sales rose 0.1% in April, which beat expectations for a 0.3% decline. Retail sales excluding autos, gas, and building materials rose 0.6%, which was also better than expected. Business inventories were flat in March, versus expectations for a 0.3% gain. In Asia, Chinese factory output grew 9.3% annually in April, which was up from 8.9% in March but still missed expectations for a 9.5% growth rate. COMPANY NEWS: The Supreme Court ruled unanimously that Monsanto's (MON) patented genetically altered soybeans are protected and that farmers cannot use them to create new seeds without paying the company... Dell's (DELL) special committee publicly asked for more information from Carl Icahn and Southeastern Asset Management about their proposed leveraged recapitalization. This request follows television interviews by Icahn last Friday in which he discussed his Dell proposal, as well as a weekend report in Barron's saying the Icahn and Southeastern plan could be a better deal for shareholders. MAJOR MOVERS: Among the notable gainers was Theravance (THRX), up $6.26, or 17.92%, to $41.20 after Elan Corporation (ELN) bought a stake in the potential future royalty payments from four respiratory programs partnered with GlaxoSmithKline (GSK) in exchange for $1B in cash. Also higher was Tesla (TSLA), which rose $11.04, or 14.38%, to $87.80 in its third straight double-digit percentage gain following a better-than-expected earnings report last week. Among the noteworthy losers was Barnes & Noble (BKS), down $2.21, or 9.48%, to $21.10 after the blog InsiderMonkey disputed a previous report about Microsoft's (MSFT) interest in the bookseller's NOOK assets. Also lower was JoS. A. Bank (JOSB), down $3.31, or 7.16%, to $42.90 after the company's first quarter earnings view came in below expectations. INDICES: The Dow was down 26.81, or 0.18%, to 15,091.68; the Nasdaq was up 2.21, or 0.06%, to 3,438.79; and the S&P 500 was nearly unchanged at 1,633.77. | | | 12:20 EDT | | GSK | On The Fly: Midday Wrap
Subscribe for More Information | | | 05:44 EDT | | GSK | Elan provides additional information on Elan/Theravance agreement
Subscribe for More Information | | | 05:35 EDT | | GSK | Theravance, Elan enter into $1B royalty participation agreement
Subscribe for More Information | | | May 10, 2013 | | 12:42 EDT | | GSK | GlaxoSmithKline, Theravance confirm FDA approval of Breo Ellipta
Subscribe for More Information | | | | 11:48 EDT |  | GSK | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information | | | 11:15 EDT | | GSK | FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
Subscribe for More Information | | | 06:53 EDT | | GSK | GlaxoSmithKline, Merck to discount cancer vaccine in poor nations, NY Times says
Subscribe for More Information | | | May 9, 2013 | | 10:08 EDT |  | JEC | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Chicago Bridge & Iron (CBI) initiated with a Buy at Deutsche Bank... Fluor (FLR) initiated with a Buy at Deutsche Bank... Infinity Pharmaceuticals (INFI) initiated with an Outperform at Wells Fargo... Jacobs Engineering (JEC) initiated with a Hold at Deutsche Bank... KBR (KBR) initiated with a Buy at Deutsche Bank... MasTec (MTZ) initiated with a Buy at Deutsche Bank... McDermott (MDR) initiated with a Hold at Deutsche Bank... Merit Medical (MMSI) initiated with a Hold at Benchmark Co... Ocean Power (OPTT) initiated with a Strong Buy at Ascendiant Capital... Quanta Services (PWR) initiated with a Buy at Deutsche Bank... ZELTIQ Aesthetics (ZLTQ) initiated with a Buy at Maxim... Evercore Partners (EVR) initiated with a Positive at Susquehanna... Alexander & Baldwin (ALEX) initiated with an Outperform at JMP Securities... Myriad Genetics (MYGN) coverage resumed with an Overweight at Stephens... Pinnacle Foods (PF) initiated with a Buy at Janney Capital. | | | May 8, 2013 | | 16:29 EDT | | JEC | Jacobs Engineering initiated with a Hold at Deutsche Bank
Target $56. | |
|
|
|
|
|
|
